Rapid onset and unpredicted findings of a giant nodular melanoma arising on a congenital nevus: a case report.


Journal

Oxford medical case reports
ISSN: 2053-8855
Titre abrégé: Oxf Med Case Reports
Pays: England
ID NLM: 101642070

Informations de publication

Date de publication:
Nov 2022
Historique:
received: 07 07 2022
revised: 20 09 2022
revised: 20 09 2022
accepted: 21 09 2022
entrez: 30 11 2022
pubmed: 1 12 2022
medline: 1 12 2022
Statut: epublish

Résumé

Melanoma is a malignancy that develops from pigment-producing cells known as melanocytes. Although it is considered one of the most fatal tumors in the world, its early diagnosis is associated with a better prognosis and overall survival. A 49-year-old man was admitted to the dermatology department with a 15 cm lesion on the left arm. It was growing on a congenital nevus to reach an enormous size. Surgical excision was not possible and the treatment was controversial as the patient showed unpredicted resistance to immunotherapy. Further evaluations revealed false-negative BRAF mutation, which completely changed the course of treatment. Cutaneous melanoma is a rare malignancy, accounting only for 1% of skin cancer cases, and having it arising on a pre-existing congenital nevus is even much rarer. Although there is no decisive definition of giant melanoma, some authors define it as a lesion of more than 10 cm in diameter. Through the literature, only a few cases of giant melanoma on the arm have been reported. Through our paper, we are revealing the importance of early diagnosis and treatment of melanoma and confirming the significant role of regular follow-up for patients with a congenital melanocytic nevus. Moreover, we are showing the importance of having alternative methods for detecting BRAF mutations to avoid false-negative results and have better outcomes.

Identifiants

pubmed: 36447470
doi: 10.1093/omcr/omac128
pii: omac128
pmc: PMC9693813
doi:

Types de publication

Case Reports

Langues

eng

Pagination

omac128

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press.

Références

Acta Neuropathol. 2012 Feb;123(2):223-33
pubmed: 22012135
South Med J. 2010 Nov;103(11):1161-2
pubmed: 20859251
BMJ Case Rep. 2016 Feb 02;2016:
pubmed: 26838295
Cancer Treat Res. 2016;167:107-29
pubmed: 26601860
Rom J Morphol Embryol. 2019;60(3):1025-1030
pubmed: 31912119
Niger J Clin Pract. 2021 May;24(5):770-773
pubmed: 34018988
Genet Mol Res. 2014 Jan 22;13(2):2840-8
pubmed: 24535907
Cancer. 1999 Jul 15;86(2):288-99
pubmed: 10421265
Clin Cosmet Investig Dermatol. 2020 Nov 13;13:837-855
pubmed: 33223843
J Am Acad Dermatol. 2003 May;48(5):694-701
pubmed: 12734497

Auteurs

Alin Mallouhy (A)

Department of Radiology, Tishreen University Hospital, Latakia, Syria.

Edwar Kounsselie (E)

Cancer Research Center, Tishreen University Hospital, Latakia, Syria.

Amira Bitar (A)

Cancer Research Center, Tishreen University Hospital, Latakia, Syria.

Ebrahim Makhoul (E)

Cancer Research Center, Tishreen University Hospital, Latakia, Syria.

Moatasem Hussein Al-Janabi (MH)

Department of Pathology, Cancer Research Center, Tishreen University Hospital, Latakia, Syria.

Zuheir Alshehabi (Z)

Department of Pathology, Cancer Research Center, Tishreen University Hospital, Latakia, Syria.

Michael Georgeos (M)

Department of Oncology, Tishreen University Hospital, Latakia, Syria.

Classifications MeSH